Zhang Lab

University of Michigan

Home Research COVID-19 Services Publications People Teaching Job Opening News Forum Lab Only

Online Services

●I-TASSER ●I-TASSER-MTD ●C-I-TASSER ●CR-I-TASSER ●QUARK ●C-QUARK ●LOMETS ●MUSTER ●CEthreader ●SEGMER ●DeepFold ●DeepFoldRNA ●FoldDesign ●COFACTOR ●COACH ●MetaGO ●TripletGO ●IonCom ●FG-MD ●ModRefiner ●REMO ●DEMO ●DEMO-EM ●DMFold ●SPRING ●COTH ●Threpp ●PEPPI ●BSpred ●ANGLOR ●EDock ●BSP-SLIM ●SAXSTER ●FUpred ●ThreaDom ●ThreaDomEx ●EvoDesign ●BindProf ●BindProfX ●SSIPe ●GPCR-I-TASSER ●MAGELLAN ●ResQ ●STRUM ●DAMpred

●TM-score ●TM-align ●US-align ●MM-align ●RNA-align ●NW-align ●LS-align ●EDTSurf ●MVP ●MVP-Fit ●SPICKER ●HAAD ●PSSpred ●3DRobot ●MR-REX ●I-TASSER-MR ●SVMSEQ ●NeBcon ●ResPRE ●TripletRes ●DeepPotential ●WDL-RF ●ATPbind ●DockRMSD ●DeepMSA ●FASPR ●EM-Refiner ●GPU-I-TASSER

●BioLiP ●E. coli ●GLASS ●GPCR-HGmod ●GPCR-RD ●GPCR-EXP ●Tara-3D ●TM-fold ●DECOYS ●POTENTIAL ●RW/RWplus ●EvoEF ●HPSF ●THE-DB ●ADDRESS ●Alpaca-Antibody ●CASP7 ●CASP8 ●CASP9 ●CASP10 ●CASP11 ●CASP12 ●CASP13 ●CASP14

GLASS

You can:

Check the ligand table for details.
Go to the GPCR list to see GPCRs with which this ligand interacts.
Go to the individual GPCR page for PubMed ID information by text mining.
Download a TSV version of all interaction data.
Go back to previous page.

Ligand

Name	FENRETINIDE
Molecular formula	C26H33NO2
IUPAC name	(2E,4E,6E,8E)-N-(4-hydroxyphenyl)-3,7-dimethyl-9-(2,6,6-trimethylcyclohexen-1-yl)nona-2,4,6,8-tetraenamide
Molecular weight	391.555
Hydrogen bond acceptor	2
Hydrogen bond donor	2
XlogP	7.3
Synonyms	33819-EP2275420A1 Fenretinimide 33819-EP2298765A1 HMS3402G21 4-(hydroxyphenyl)retinamide LXS/4-HPR 65646-68-6 N-(4-hydroxyphenyl)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraenamide AKOS024456572 NCGC00090752-02 BP-13369 RETINOID PROJECT 6 (4-HPR) (SEE RETINOID PROJECTS 1,2,3,4,5) NCGC00090752-11 Spectrum5_001939 p-Hydroxyphenylretinamide DSSTox_GSID_32005 Tox21_200989 Fenretinide (Ewing's sarcoma), Cancer Research UK (2E,4E,6E,8E)-N-(4-hydroxyphenyl)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-enyl)nona-2,4,6,8-tetraenamide Fenretinide (pulmonary Pseudomonas aeruginosa infections in cystic fibrosis), McGill University Fenretinide (topical, actinic keratosis and cancer), SciTech Development 33819-EP2295416A2 HMS1361G21 33819-EP2311808A1 IDI1_033889 4-hydroxy(phenyl)retinamide MLS001055399 AB0109574 N-(4-Hydroxyphenyl)-trans-Retinamide AN-7467 NCGC00090752-05 CAS-65646-68-6 SCHEMBL11703 NCGC00261310-01 D04162 SR-01000075917-4 Retinamide,N-(4-hydroxyphenyl)- EU-0100625 W-5119 Fenretinide (intravenous emulsion, lymphoma/solid tumors/pediatric neuroblastomas/pediatric leukemia), CerRx 15-(4-Hydroxyanilino)retinal # Fenretinidum 33819-EP2298748A2 HMS2089B17 4 HPR LP00625 4HPR MolPort-003-666-842 AK326150 N-(4-hydroxyphenyl)retinamide, 4-HPR BDBM50092055 RETINOID PROJECT 4 (4-HYDROXYPHENYL)RETINAMIDE (SEERETINOID PROJECT 1, 2, AND 3) NCGC00090752-09 CHEBI:42588 SMR000677938 NSC374551 dimethyl-9-(2,6,6-trimethylcyclohex- Tox21_111007 Retinoic acid p-hydroxyphenylamide (2E,4E,6E,8E)-N-(4-Hydroxyphenyl)-3,7-dimethyl-9-(2,6,6-trimethyl-1-cyclohexenyl)nona-2,4,6,8-tetraenamide Fenretinide (oral powder/Lym-X-Sorb, neuroblastoma), BioMolecular Products 2,6,8-Nonatetraenamide, N-(4-hydroxyphenyl)-3,7-dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl-, (all-E)- 33819-EP2295055A2 FT-0081247 33819-EP2305642A2 HSCI1_000112 4-HPR McN-R-1967 A835178 N-(4-Hydroxyphenyl)-all-trans Retinamide all-trans-4'-Hydroxyretinanilide NCGC00090752-03 BRN 5769490 RT-101 NCGC00090752-12 CHEMBL7301 SR-01000075917 Pharmakon1600-01505602 DSSTox_RID_78900 Tox21_500625 Fenretinide (ILE formulation), Children's Hospital LA (2E,4E,6E,8E)-N-(4-hydroxyphenyl)-3,7-dimethyl-9-(2,6,6-trimethylcyclohexen-1-yl)nona-2,4,6,8-tetraenamide Fenretinide (soft gel capsule, AMD), ReVision Therapeutics Fenretinide (USAN/INN) 33819-EP2295426A1 HMS1791G21 33819-EP2311829A1 KB-77316 4-Hydroxyphenyl retinamide MLS002701698 AC1NRB1E N-(4-Hydroxyphenyl)all-Trans Retinamide AOB6402 NCGC00090752-06 CCG-204713 SCHEMBL11704 NSC-374551 D08JAC ST-602 Retinoic acid p-hydroxyanilide Fenretinida ZINC3871023 (2E,4E,6E,8E)-3,7-Dimethyl-9-(2,6,6-trimethyl-cyclohex-1-enyl)-nona-2,4,6,8-tetraenoic acid (4-hydroxy-phenyl)-amide Fenretinide (intravenous, cancer), SciTech Development 15-[(4-hydroxyphenyl)amino]retinal 3,7-Dimethyl-9-(2,6,6-trimethyl-cyclohex-1-enyl)-nona-2,4,6,8-tetraenoic acid (4-hydroxy-phenyl)-amide Fenretinidum [Latin] 33819-EP2298764A1 HMS3261N12 4-(HYDROXYPHENYL)-RETINAMIDE (SEE RETINOID PROJECTS 1 AND 2.) LS-282 646F686 N-(4-Hydroxyphenyl)-3,7-dimethyl-9-(2,6,6-trimethyl-1-cyclohexenyl)-2,4,6,8-nonatetraeneamide AKJHMTWEGVYYSE-FXILSDISSA-N NCGC00090752-01 BML2-E08 RETINOID PROJECT 5 (4-HYDROXYPHENYL)RETINAMIDE (SEERETINOID PROJECT 1, 2, 3, 4) NCGC00090752-10 CHEBI:92493 SMR001456303 NSC760419 DSSTox_CID_12005 Tox21_111007_1 Fenretinide (4-HPR) (2E,4E,6E,8E)-N-(4-hydroxyphenyl)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraenamide Fenretinide (oral, AMD), Sytera 33819-EP2295406A1 H 7779 33819-EP2311453A1 HY-15373 4-HPR;(4-Hydroxyphenyl)retinamide MFCD00792674 AB00172992-07 N-(4-hydroxyphenyl)-retinamide all-trans-n-(4-hydroxyphenyl)retinamide NCGC00090752-04 BSPBio_001419 SC-76490 NCGC00258542-01 CS-0789 SR-01000075917-1 Retinamide, N-(4-hydroxyphenyl)- DTXSID2032005 UNII-187EJ7QEXL Fenretinide (intralipid emulsion formulation), Children's Hospital of Los Angeles 1-enyl)nona-2,4,6,8-tetraenamide Fenretinide (soft gel capsule, AMD), Sirion Fenretinide [USAN:INN] 33819-EP2295427A1 HMS1989G21 3670AH Lopac0_000625 4-hydroxyphenylretinamide MLS006010811 AC1Q1QV3 N-(4-Hydroxyphenyl)retinamide BCP06908 RETINOID PROJECT 2 (4-(HYDROXYPHENYL)RETINAMIDE) (SEE RETINOID PROJECT 1,3,4, 5,6) NCGC00090752-07 CCRIS 3260 SCHEMBL15703189 NSC-760419 DB05076 SYT-101 Retinoic acid p-hydroxyanilide, >=95% Fenretinida [Spanish] (2E,4E,6E,8E)-N-(4-hydroxyphenyl)-3,7- Fenretinide (iv), Children's Hospital LA 187EJ7QEXL [ Show all ]
Inchi Key	AKJHMTWEGVYYSE-FXILSDISSA-N
Inchi ID	InChI=1S/C26H33NO2/c1-19(11-16-24-21(3)10-7-17-26(24,4)5)8-6-9-20(2)18-25(29)27-22-12-14-23(28)15-13-22/h6,8-9,11-16,18,28H,7,10,17H2,1-5H3,(H,27,29)/b9-6+,16-11+,19-8+,20-18+
PubChem CID	5288209
ChEMBL	CHEMBL7301
IUPHAR	N/A
BindingDB	N/A
DrugBank	N/A
Structure SDF download
Lipinski's druglikeness	This ligand has a partition coefficient log P greater than 5.

Known GPCRs

You can:

Click GLASS IDs to check the association information.
Click protein names to check details of the GPCRs.
Download a TSV version of all interaction information.

GLASS ID	Name	UniProt	Gene	Species	Length
7605	D(1A) dopamine receptor	P21728	DRD1	Homo sapiens (Human)	446
7606	Glucagon-like peptide 1 receptor	P43220	GLP1R	Homo sapiens (Human)	463

zhanglabzhanggroup.org | (734) 647-1549 | 100 Washtenaw Avenue, Ann Arbor, MI 48109-2218